hendystreet_faint_neuron_for_slide_decks_with_different_blue__ea9a1a30-381f-445b-bdf2-ebd1e1140b06_1.png

CONNECTIONS THAT MATTER

We are a go-to-resource for all our clients drug development needs and services. We understand that every connection matters, and if we do not have the expertise in-house, we will introduce you to who does through industry partnerships.

    • BIOANALYTICAL LABS

    • CMC

    • CDMO

    • CENTRAL LABS

    • LAB AUDIT & IDENTIFICATION

    • LAB CONSULTING - BIOANALYTICAL & CMC

    • SINGLE DOSE / REPEAT DOSE STUDIES

    • IN VIVO ADME & PK STUDIUES

    • PHARMACLOGY AND BEHAVIORAL MODELS

    • AUTOMATED ALMOST REALTIME TK AND PK REPORT

    • NONGLP AND GLP TK ANALYSIS AND REPORTING

    • PK, PD & POP PK ANALYSIS FROM NONCLINICAL THROUGH COMMERCIALIZATION

    • MODEL INFORMED DRUG DEVELOPMENT

    • NONCLINICAL REPORT WRITING IN 1 DAY - COMING SOON

    • IND/CTA READINESS AND GAP ANALYSIS CONSULTING

    • IND/CTA WRITING & SUBMISSIONS

    • ATTEND PRE-IND METTINGS AND PK & REGULATORY EXPERTS

    • MOCK MEETINGS & PREPARATION

    • CLINICAL PHARMACOLOGY PROTOCOL WRITING

    • CLINICAL PHARMACOLOGY PLANNING

    • PHARMACOKINETICIST DOSE AMD SAMPLING SCHEDULE REVIEW AND INPUT TO PROTOCOL

    • PK & PD ANALYSIS AND REPORTING

    • MODEL INFORMED DRUG DEVELOPMENT (MIDD)

    • CRU IDENTIFICATION & SITE AUDIT FOR BIOTECH CLIENTS

    • OUTSOURCE MANAGEMENT

    • PROPOSAL DEVELOPMENT

    • PROPOSALREVIEW

    • CONTRACT MANAGEMENT

    • GOVERNANCE

    • PROCESS DEVELOPMENT AND/OR IMPROVEMENT

    • SOP GENERATION

    • CRO SALES FORECASTING

    • CRO ANNUAL SALES TARGETS

    • CRO QBR DEVELOPMENT

    • BIOTECH PITCH DECK

    • CLINICAL CALL CENTER

    • DATA MANAGEMENT

    • DRUG DISTRIBUTION & LOGISTICS

    • BIOSTATISTICS

    • PHARMACOVIGALANCE

    • NEUROLOGY SITES NC - COMMING SOON

    • RARE & UNMET MEDICAL NEEDS

    • PATIENT INTEGRATION EARLY ON FOR INSIGHTS PROTOCOL DEVELOPMENT (CROS & BIOTECHS

    • PATIENT INPUT ON FEASABILITY AND ENGAGEMENT - RETENTION

    • PRO - FEEDBACK FOR ENGAGEMENT

    • ACTIVE STUDY ATTRACTIVENESS COMPARATOR

    • BID DEFENSE MEETING (CRO TELL THE STORY, BIOTECH - STRATEGY ASSESSMENT

    • NATURAL HISTORY

    • QUALITY OF LIFE (PATIENT & SUPPORT ADVOCATE)

    • LONG-TERM FOLLOW UP STUDIES

    • PATIENT JOURNEY MAPPING

    • HEALTH ECONOMICS & OUTCOMES RESEARCH

Bridging Science, Expertise, & Innovation - through FSO, FSP, FTE Models

At SYNAPTIGEN, we believe that the small connections matter—whether it’s bridging patients and research, biotech and clinical expertise, or data and actionable insights. Our Connections That Matter services are designed to streamline collaboration, enhance patient engagement, and drive meaningful progress in clinical research and drug development. We work to break down silos between stakeholders, ensuring that every link in the research and development chain is purposeful, strategic, and patient-centered.

Through a patient-first approach, we help shape clinical trial designs that prioritize real-world patient needs, ensuring that new therapies are accessible, effective, and feasible. Our expertise extends to fostering industry partnerships, aligning with regulatory expectations, and leveraging scientific innovation to support biotechs, CROs, and advocacy organizations in creating impactful, patient-driven solutions. Whether it’s connecting key stakeholders, refining trial feasibility, or integrating advocacy into research, our approach ensures that every connection leads to measurable, meaningful progress in advancing healthcare solutions.